Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tandile Modise"'
Autor:
Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, Rebecca T van Dorsten, Amanda S Woodward Davis, Nicolas Beaume, David Matten, Bronwen Lambson, Tandile Modise, Prudence Kgagudi, Talita York, Dylan H Westfall, Elena E Giorgi, Bette Korber, Colin Anthony, Rutendo E Mapengo, Valerie Bekker, Elizabeth Domin, Amanda Eaton, Wenjie Deng, Allan DeCamp, Yunda Huang, Peter B Gilbert, Asanda Gwashu-Nyangiwe, Ruwayhida Thebus, Nonkululeko Ndabambi, Dieter Mielke, Nyaradzo Mgodi, Shelly Karuna, Srilatha Edupuganti, Michael S Seaman, Lawrence Corey, Myron S Cohen, John Hural, M Juliana McElrath, James I Mullins, David Montefiori, Penny L Moore, Carolyn Williamson, Lynn Morris
Publikováno v:
PLoS Pathogens, Vol 19, Iss 6, p e1011469 (2023)
The VRC01 Antibody Mediated Prevention (AMP) efficacy trials conducted between 2016 and 2020 showed for the first time that passively administered broadly neutralizing antibodies (bnAbs) could prevent HIV-1 acquisition against bnAb-sensitive viruses.
Externí odkaz:
https://doaj.org/article/1a870a5047ec41f0af5508300c65082a
Autor:
Sharana Mahomed, Nigel Garrett, Edmund V Capparelli, Farzana Osman, Ishana Harkoo, Nonhlanhla Yende-Zuma, Tanuja N Gengiah, Derseree Archary, Natasha Samsunder, Cheryl Baxter, Nonhlanhla N Mkhize, Tandile Modise, Kevin Carlton, Adrian McDermott, Penny L Moore, Quarraisha Abdool Karim, Dan H Barouch, Patricia E Fast, John R Mascola, Julie E Ledgerwood, Lynn Morris, Salim S Abdool Karim
Publikováno v:
The Journal of Infectious Diseases. 226:510-520
Background Effective, long-acting prevention approaches are needed to reduce human immunodeficiency virus (HIV) incidence. We evaluated the safety and pharmacokinetics of VRC07-523LS and PGT121 administered subcutaneously alone and in combination as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d666622cd9edfb7d1a64b1580f4cc7
https://doi.org/10.1093/infdis/jiac041
https://doi.org/10.1093/infdis/jiac041